1. Cell Biology
Download icon

One-shot analysis of translated mammalian lncRNAs with AHARIBO

  1. Luca Minati
  2. Claudia Firrito
  3. Alessia Del Piano
  4. Alberto Peretti
  5. Simone Sidoli
  6. Daniele Peroni
  7. Romina Belli
  8. Francesco Gandolfi
  9. Alessandro Romanel
  10. Paola Bernabo
  11. Jacopo Zasso
  12. Alessandro Quattrone
  13. Graziano Guella
  14. Fabio Lauria
  15. Gabriella Viero
  16. Massimiliano Clamer  Is a corresponding author
  1. IMMAGINA biotechnology, Italy
  2. Albert Einstein College of Medicine, United States
  3. University of Trento, Italy
  4. CNR Unit at Trento, Italy
Tools and Resources
  • Cited 0
  • Views 355
  • Annotations
Cite this article as: eLife 2021;10:e59303 doi: 10.7554/eLife.59303

Abstract

A vast portion of the mammalian genome is transcribed as long non-coding RNAs (lncRNAs) acting in the cytoplasm with largely unknown functions. Surprisingly, lncRNAs have been shown to interact with ribosomes, encode peptides, or act as ribosome sponges. These functions still remain mostly undetected and understudied owing to the lack of efficient tools for genome-wide simultaneous identification of ribosome-associated and peptide-producing lncRNAs. Here we present AHARIBO, a method for the detection of lncRNAs either untranslated, but associated with ribosomes, or encoding small peptides. Using AHARIBO in mouse embryonic stem cells during neuronal differentiation, we isolated ribosome-protected RNA fragments, translated RNAs and corresponding de novo synthesized peptides. Besides identifying mRNAs under active translation and associated ribosomes, we found and distinguished lncRNAs acting as ribosome sponges or encoding micropeptides, laying the ground for a better functional understanding of hundreds lncRNAs.

Article and author information

Author details

  1. Luca Minati

    Ribosome engineering, IMMAGINA biotechnology, Trento, Italy
    Competing interests
    Luca Minati, L.M is an employee of IMMAGINA BioTechnology S.r.l..
  2. Claudia Firrito

    Ribosome engineering, IMMAGINA biotechnology, Trento, Italy
    Competing interests
    Claudia Firrito, C.F. is an employee of IMMAGINA BioTechnology S.r.l..
  3. Alessia Del Piano

    Ribosome engeneering, IMMAGINA biotechnology, Trento, Italy
    Competing interests
    Alessia Del Piano, A.D.P is an employee of IMMAGINA BioTechnology S.r.l..
  4. Alberto Peretti

    Ribosome engineering, IMMAGINA biotechnology, Trento, Italy
    Competing interests
    Alberto Peretti, A.P. is an employee of IMMAGINA BioTechnology S.r.l..
  5. Simone Sidoli

    Department of Biochemistry, Albert Einstein College of Medicine, Bronx, United States
    Competing interests
    No competing interests declared.
  6. Daniele Peroni

    Mass Spectrometry Facility, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0862-266X
  7. Romina Belli

    Mass Spectrometry Facility, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5690-2797
  8. Francesco Gandolfi

    Laboratory of Bioinformatics and Computational Genomics, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy
    Competing interests
    No competing interests declared.
  9. Alessandro Romanel

    Laboratory of Bioinformatics and Computational Genomics, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy
    Competing interests
    No competing interests declared.
  10. Paola Bernabo

    Ribosome engineering, IMMAGINA biotechnology, Trento, Italy
    Competing interests
    Paola Bernabo, P.B is an employee of IMMAGINA BioTechnology S.r.l..
  11. Jacopo Zasso

    Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3151-6443
  12. Alessandro Quattrone

    Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy
    Competing interests
    Alessandro Quattrone, A.Q is a shareholder of IMMAGINA BioTechnology S.r.l.
  13. Graziano Guella

    Department of Physics, University of Trento, Trento, Italy
    Competing interests
    Graziano Guella, G.G. is shareholders of IMMAGINA BioTechnology S.r.l.
  14. Fabio Lauria

    Institute of Biophysics, CNR Unit at Trento, Trento, Italy
    Competing interests
    No competing interests declared.
  15. Gabriella Viero

    Institute of Biophysics, CNR Unit at Trento, Trento, Italy
    Competing interests
    Gabriella Viero, G.V is a scientific advisor of IMMAGINA BioTechnology S.r.l..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6755-285X
  16. Massimiliano Clamer

    Ribosome engineering, IMMAGINA biotechnology, Trento, Italy
    For correspondence
    mclamer@immaginabiotech.com
    Competing interests
    Massimiliano Clamer, M.C. is the founder of, director of, and a shareholder in IMMAGINA BioTechnology S.r.l., a company engaged in the development of new technologies for gene expression analysis at the ribosomal level..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8185-059X

Funding

Autonumus Province of Trento adn Banca Intesa (LP6/99)

  • Luca Minati
  • Claudia Firrito
  • Alessia Del Piano
  • Alberto Peretti
  • Paola Bernabo
  • Massimiliano Clamer

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Howard Y Chang, Stanford University, United States

Publication history

  1. Received: May 25, 2020
  2. Accepted: February 16, 2021
  3. Accepted Manuscript published: February 17, 2021 (version 1)

Copyright

© 2021, Minati et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 355
    Page views
  • 91
    Downloads
  • 0
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

Further reading

    1. Cell Biology
    2. Neuroscience
    Javier Emperador-Melero et al.
    Research Advance

    It has long been proposed that Leukocyte common Antigen-Related Receptor Protein Tyrosine Phosphatases (LAR-RPTPs) are cell-adhesion proteins that control synapse assembly. Their synaptic nanoscale localization, however, is not established, and synapse fine structure after knockout of the three vertebrate LAR-RPTPs (PTPδ, PTPσ and LAR) has not been tested. Here, superresolution microscopy reveals that PTPδ localizes to the synaptic cleft precisely apposed to postsynaptic scaffolds of excitatory and inhibitory synapses. We next assessed synapse structure in newly generated triple-conditional knockout mice for PTPδ, PTPσ and LAR, complementing a recent independent study of synapse function after LAR-RPTP ablation (Sclip and Südhof, 2020). While mild effects on synaptic vesicle clustering and active zone architecture were detected, synapse numbers and their overall structure were unaffected, membrane anchoring of the active zone persisted, and vesicle docking and release were normal. Hence, despite their localization at synaptic appositions, LAR-RPTPs are dispensable for presynapse structure and function.

    1. Cell Biology
    2. Stem Cells and Regenerative Medicine
    Carolina Ortiz-Cordero et al.
    Research Article Updated

    Mutations in the fukutin-related protein (FKRP) cause Walker-Warburg syndrome (WWS), a severe form of congenital muscular dystrophy. Here, we established a WWS human induced pluripotent stem cell-derived myogenic model that recapitulates hallmarks of WWS pathology. We used this model to investigate the therapeutic effect of metabolites of the pentose phosphate pathway in human WWS. We show that functional recovery of WWS myotubes is promoted not only by ribitol but also by its precursor ribose. Moreover, we found that the combination of each of these metabolites with NAD+ results in a synergistic effect, as demonstrated by rescue of α-dystroglycan glycosylation and laminin binding capacity. Mechanistically, we found that FKRP residual enzymatic capacity, characteristic of many recessive FKRP mutations, is required for rescue as supported by functional and structural mutational analyses. These findings provide the rationale for testing ribose/ribitol in combination with NAD+ to treat WWS and other diseases associated with FKRP mutations.